Patients, doctors await FDA decision on experimental Alzheimer's drug
Lecanemab: It's an experimental medication that's been shown in trials to slow cognitive decline in people with Alzheimer's disease.
Jan 6, 2023
0
6
Lecanemab: It's an experimental medication that's been shown in trials to slow cognitive decline in people with Alzheimer's disease.
Jan 6, 2023
0
6
A team of scientists at Sweden's Linköping University has developed a molecular probe that can detect an array of different amyloid deposits in several human tissues. This new probe is extremely sensitive and was used at ...
Mar 21, 2016
0
0
Researchers at Washington University School of Medicine in St. Louis have devised a method to gauge Alzheimer's disease severity by analyzing the patterns of tau pathology in brain scans. The findings could lead to a way ...
May 15, 2024
0
0
Calcific aortic valve disease (CAVD) is the major heart valve disease that afflicts nearly 10 million patients globally with an annual mortality exceeding 100,000, and the numbers continue to rise.
Jun 5, 2024
0
0
A research team has confirmed that brain amyloid-β (Aβ) deposition, a biomarker for Alzheimer's disease, is an essential predictor for post-stroke cognitive impairment (PSCI) development and cognitive decline after small-sized ...
Jan 10, 2024
0
0
New research findings from the Center for Cognitive Neurology at NYU Langone Medical Center could provide additional clues for future treatment targets to delay Alzheimer's disease and related dementias. This is according ...
Jul 28, 2016
0
3
In June 2016, the German national football team was gearing up to face Slovakia in the European championship. With pulses set to race among thousands of fans in the crunch match in host country France, a group of scientists ...
Jun 12, 2024
0
0
Injection of a novel form of synthetic high-density lipoprotein cholesterol (HDL-C), or good cholesterol, into the arteries of patients who had recently had a heart attack did not reduce the volume of fatty deposits, or plaque, ...
Mar 20, 2017
0
0
The presence of beta-amyloid deposits in the brain significantly limits the effectiveness of cognitive training in healthy older adults, according to new research presented at the 2024 Society of Nuclear Medicine and Molecular ...
Jun 10, 2024
0
0